Market News

Breaking headlines and analysis across every asset class.

Markets
TradingKey • Sep 26, 2026
Sumitomo Mitsui Financial Group Inc Stock (SMFG) Moved Up by 3.80% on Sep 25: What Signal Does It Send?

Sumitomo Mitsui Financial Group Inc (SMFG) saw its stock rise by 3.80% on September 25, outperforming its sector. This surge was attributed to rising Japanese government bond yields, which widened net interest margins, and strategic corporate news, including discussions to increase its stake in Vietnam's VPBank. Despite this positive movement, technical indicators suggest a neutral to buy condition, and fundamental analysis highlights both strong revenue and profit, alongside company-specific ri

Markets
MarketBeat • Sep 26, 2026
Abacus Global Management, Inc. (NYSE:ABX) Stock Now Rated "Moderate Buy" by Sell-Side Analysts

Sell-side analysts have given Abacus Global Management, Inc. (NYSE:ABX) a "Moderate Buy" consensus rating with an average 12-month price target of $12.00, above its current $8.32 share price. The company recently completed a $400 million investment-grade securitization of life-insurance assets, oversubscribed due to strong institutional demand, enhancing its funding capacity and supporting a shift towards recurring revenue. Despite significant insider selling totaling $6.6 million over the past

Markets
MarketBeat • Sep 26, 2026
Spyglass Pharma, Inc. (NASDAQ:SGP) Stock Has Average Target Price of $44.00

Spyglass Pharma, Inc. (NASDAQ:SGP) has an average 12-month price target of $44.00 from eight analysts, indicating a "Moderate Buy" consensus despite the company missing its last quarterly earnings estimate. The clinical-stage company, which focuses on long-acting ophthalmic drug-delivery treatments like its SGP-310 implant for glaucoma, reported a quarterly loss of $0.59 per share. Several institutional investors have recently established positions in the company, which has a market cap of $904.

Markets
MarketBeat • Sep 26, 2026
BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) Receives Consensus Rating of "Moderate Buy" from Brokerages

BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) has received a "Moderate Buy" consensus rating from six analysts, with an average 12-month price target of $35.00. This comes despite the company missing its quarterly EPS estimate significantly, reporting -$8.75 against a consensus of -$0.84. Insider buying activity was strong, with company insiders acquiring 1.57 million shares worth approximately $25.2 million in the last quarter, including notable purchases by Orbimed Advisors and Bihua Chen at $1

Markets
Yahoo Finance Singapore • Sep 26, 2026
Morgan Stanley (MS) Joins Prediction Market Push In A First For Major Banks

Morgan Stanley (MS) has become the first major Wall Street bank to formally partner with a prediction market initiative by collaborating with NEXTPredict. This move aligns with Morgan Stanley's strategy to leverage its data and technology to enhance advisory services and explore new fee-based formats, similar to how other rivals are exploring AI and private markets. While it supports the bank's data-informed advisory platform, the monetization aspect and client willingness to pay for these new t

Markets
Simply Wall Street • Sep 26, 2026
Public Storage (PSA), Why Is It Getting Fresh Attention Now?

Public Storage (PSA) is receiving fresh attention due to a slowdown in self-storage development and mixed operating results in the industry. Despite recent share price dips, the company is seen by some as undervalued, trading below analyst targets and intrinsic value, especially after large acquisitions. However, others view its P/E ratio as rich, suggesting caution due to execution risks and a high dividend payout ratio.

Markets
Investing.com • Sep 26, 2026
General Dynamics director Robert Steel sells $2.57m in stock

Robert K. Steel, a director at General Dynamics Corp, sold 7,440 shares of the company's common stock for $2.57 million after acquiring an equal number through exercised stock options. Following these transactions, Steel directly owns 3,096 shares. The company has also recently secured multiple significant military contracts.

Markets
Yahoo! Finance Canada • Sep 26, 2026
The Cooper Companies, Inc. (COO) Stock Price, News, Quote & History

This article provides detailed financial information for The Cooper Companies, Inc. (COO), including its current stock price, recent performance metrics, and key financial ratios. It covers the company's business segments—CooperVision and CooperSurgical—and offers analyst insights, earnings trends, and a performance comparison against the S&P 500. The data presented reflects activity up to September 25, 2026.

Get Headlines in Your Inbox

One email a day with the market-moving stories you actually need to read.